DeepMed Research

MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Phase 2

Completed

Conditions: Leukemia
Lymphoma
Lymphoproliferative Disorder

Interventions: Drug: Everolimus

First Posted Date: 2007-02-19

Last Posted Date: 2019-10-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 277

Registration Number: NCT00436618

Locations: 🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States

Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin

Phase 2

Completed

Conditions: Ovarian Cancer
Peritoneal Cavity Cancer

Interventions: Drug: Lapatinib
Drug: Topotecan

First Posted Date: 2007-02-19

Last Posted Date: 2014-04-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 18

Registration Number: NCT00436644

Locations: 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Jacksonville, Jacksonville, Florida, United States

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Phase 2

Completed

Conditions: Cardiac Toxicity
Breast Cancer

First Posted Date: 2007-02-19

Last Posted Date: 2022-08-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 122

Registration Number: NCT00436566

Locations: 🇺🇸
Mayo Clinic Cancer Research Consortium, Rochester, Minnesota, United States

Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Not Applicable

Completed

Conditions: Osteoporosis
Breast Cancer

Interventions: Drug: zoledronic acid
Procedure: Letrozole as adjuvant therapy

First Posted Date: 2007-02-19

Last Posted Date: 2019-09-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT00436917

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia

Phase 2

Completed

Conditions: Leukemia

Interventions: Drug: Alemtuzumab
Drug: Rituximab

First Posted Date: 2007-02-19

Last Posted Date: 2011-12-01

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT00436904

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders

Early Phase 1

Completed

Conditions: Chronic Myeloproliferative Disorders
Leukemia

Interventions: Drug: PS-341

First Posted Date: 2007-02-19

Last Posted Date: 2014-10-17

Lead Sponsor: Mayo Clinic

Target Recruit Count: 30

Registration Number: NCT00437086

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Does DHEA Enhance the Effects of Exercise in Postmenopausal Women?

Not Applicable

Completed

Conditions: Aging

First Posted Date: 2007-02-14

Last Posted Date: 2011-03-23

Lead Sponsor: Mayo Clinic

Target Recruit Count: 32

Registration Number: NCT00434915

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes

Phase 4

Completed

Conditions: Obesity

Interventions: Drug: sibutramine

First Posted Date: 2007-02-12

Last Posted Date: 2011-03-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 181

Registration Number: NCT00433641

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma

Phase 3

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

Interventions: Drug: Thalidomide
Drug: zoledronic acid

First Posted Date: 2007-02-07

Last Posted Date: 2012-07-04

Lead Sponsor: Mayo Clinic

Target Recruit Count: 68

Registration Number: NCT00432458

Locations: 🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States

and more 1 locations

Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men

Phase 1

Completed

Conditions: Hypogonadism

First Posted Date: 2007-02-05

Last Posted Date: 2010-01-28

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT00431197

Locations: 🇺🇸
Mayo Clinic and Foundation, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy